Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$30,000.00
Aug 1, 2023
For-profit organization
Lab support
1008536
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. A new technical resource will perform work and analytical screening on the development of Ripple’s local, sustained drug delivery technology for targeted applications and on the maintenance of Ripple's wet chemistry laboratory in Toronto. The position will have a role in analytical testing, lab maintenance, developing test methods and documenting technical processes to support new discovery within Ripple’s drug delivery platform technology.
$22,984.00
Sep 1, 2022
For-profit organization
Sustained release form targeting wet age-related macular degeneration
995494
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. Scientific and engineering resources will perform work on
the development of a novel compound for the treatment of Neovascular age-related macular degeneration (nAMD). The project will require synthesizing novel compounds and performing materials characterization and in vitro evaluations to assess for potential lead compounds for the next stages of development.
$30,000.00
Apr 1, 2022
For-profit organization
Associate research scientist
989530
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. A new scientific resource will perform work on the development of Ripple’s local, sustained drug delivery technology for targeted applications. The position will have a role in prototyping, characterization, and testing of novel molecular compounds and materials in support of Ripple’s drug delivery platform technology.
$810,564.00
Jan 1, 2022
For-profit organization
IBE-814 IVT Diabetic Macular Edema and Retinal Vein Occlusion
986775
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. Scientific and engineering resources will perform work on the development of Ripple’s lead product IBE-814 IVT for the treatment of Diabetic Macular Edema and Retinal Vein Occlusion. The project will require analysis of data generated from the ongoing clinical trial, and development and scale up of the product for the next stages on the path to commercialization.
$50,000.00
Nov 16, 2021
For-profit organization
Development of New Materials for the Treatment of Opioid use disorder
982618
The goal of this project is to engineer unique drug delivery systems using prodrug materials that will improve upon current controlled drug release technologies for the treatment of opioid use disorder. This will involve evaluating chemically modifying an API so that it can be processed into a sustained release injectable form that exhibits surface erosion based drug release without the use of polymers or excipients. This work will be pursued for APIs in the opioid antagonist drug class
$40,000.00
Aug 3, 2021
For-profit organization
Lab resource 2021
972934
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. A new scientific resource will perform work on the development of Ripple’s local, sustained drug delivery technology for targeted applications. The position will have a role in prototyping, characterization, and testing of novel molecular compounds in support of Ripple’s drug delivery platform technology.
$35,000.00
Jul 6, 2021
For-profit organization
Finance resource 2021
972823
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. Ripple has a a number of candidate pipeline products in development and a business development and accounting resource is needed to perform market research on pipeline and partnering opportunities and ensure key metrics are appropriately recorded and analyzed on our programs.
$162,624.00
Apr 1, 2020
For-profit organization
Innovation Assistance Program
950924
The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.